Analysts Are Updating Their Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Estimates After Its Annual Results
Last week, you might have seen that Deciphera Pharmaceuticals, Inc. ( NASDAQ:DCPH ) released its annual result to the...
Stay updated with breaking news from Deciphera Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last week, you might have seen that Deciphera Pharmaceuticals, Inc. ( NASDAQ:DCPH ) released its annual result to the...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Is Deciphera Pharmaceuticals' Stock Undervalued? A Comprehensive Analysis of Its Market Value
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities research analysts at SVB Leerink cut their Q2 2023 EPS estimates for shares of Deciphera Pharmaceuticals in a research note issued to investors on Wednesday, May 3rd. SVB Leerink analyst A. Berens now forecasts that the company will earn ($0.65) per share for the quarter, down […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Research analysts at SVB Leerink decreased their FY2025 earnings estimates for shares of Deciphera Pharmaceuticals in a research note issued on Tuesday, April 25th. SVB Leerink analyst A. Berens now forecasts that the company will post earnings per share of $0.26 for the year, down from their […]